Post-IPO Equity Companies in Waltham

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Vicarious Surgical is a robotics company that develops robotic systems that allow surgeons to perform minimally invasive surgery.

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Bigtincan is a sales enablement automation company that helps brands facilitate the future buying experience.